Tag: Medicare Part B reimbursement
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Nitroglycerin vs Alternatives: Which Angina Treatment Works Best?
Oct, 11 2025
Lamivudine Cost-Effectiveness for HIV and Hepatitis B Treatment: Real-World Insights
May, 11 2025
Energy Drinks and Stimulant Medications: How They Raise Blood Pressure and Heart Risks
Dec, 8 2025
How Generic Drugs Saved the U.S. Healthcare System $3.4 Trillion
May, 25 2026
The connection between pharyngeal mucous membranes and bad breath
Sep, 4 2023